Unlocking the secrets of our passion and expertise

Everything you need to know about AHB Lab

Who are we?

A Developing Novel Biosynthetic Peptide Manufacturer

AHB Lab is the Taiwan biotech pioneer company focusing on the devel- opment and supply of novel biosynthetic peptide and their commercialized products with self-developed core technology “Synthetic Biology Peptido- mimetic Platform (SBPP)”. SBPP is completed in mass production process for dipeptides to henicosapeptide with low-cost and high-yield way, aiming at peptide-based therapy relevant in cosmetics, nutraceuticals, medicine. At present, 11 biosynthetic peptide materials and 4 biosynthetic peptide-based series of products have been completed.

The biosynthetic peptides for the treatment of degenerative arthritis, and its medical application has obtained 6 international invention patents from Taiwan, Japan, and China. Broad patent portfolio of 18 patent applications covering 6 key markets will cover new indication of biosynthetic peptide for treatment of degenerative arthritis, tendon fasciitis, ligamentitis, oral muco- sal wound healing, sleep aid, immunity enhancement, prostate mainte- nance, gastroesophageal reflux, intestinal health, diabetes, cardiovascular, liver function, osteoporosis, rheumatoid arthritis, inflammatory storm, anti-aging, anti-tumor, life extension, sexual dysfunction, blood circulation, increase blood oxygen and nitric oxide level, anti-wrinkle, reduce fine lines.

 

Company Introductions
Biosynthetic peptide materials
0
Biosynthetic peptide-based series of products
0
International invention patents worldwide
0
Broad patent portfolio
0

Meet our professional teams that makes everything happen

We are creating tomorrow's solutions today

Team Member

KUO-SHENG CHUANG

Chairman / CEO

Team Member

SIN-TANG SONG

Vice Chairman

Patrick Wang

YUN C. YUNG

R&D Consultant

Team Member

YAN-LING CHEN

Vice President of Overseas Business Department